LNTH-2511

N/A

Report date: 2025/12/04 09:33:15

Base Information

Drug NameLNTH-2511
Drug Alias NameN/A
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Fluorine
Mechanisms of ActionMonoamine oxidase B modulators
TargetsMonoamine oxidase B
Therapy Area/IndicationsNeuroinflammatory Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLantheus Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings Inc
Inactive CompaniesN/A
Active IndicationsNeuroinflammatory Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A